Thu, Apr 17, 2014, 8:33 AM EDT - U.S. Markets open in 57 mins.

Recent

% | $
Quotes you view appear here for quick access.

Regenerx Biopharmaceuticals Inc. Message Board

  • snogreen snogreen Jul 15, 2011 1:34 PM Flag

    TB4 in human Diabetes trial

    Here's a new one for you. TB 4 has already BEN tested IN HIUMANS..in a Type 2 Diabetes trial. The researchers claimed there was statistical significance in the higher sugar level group. It was a placebo controlled trial. There were 26 HUMANS, not mice. After that they also did a dog diabetes test.

    The researchers put all this in their Patent application. Here it is:

    http://worldwide.espacenet.com/publicationDetails/biblio?CC=GB&NR=2476789A&KC=A&FT=D&date=20110713&DB=EPODOC&locale=en_ep

    Read under "original Document". Then go to page 17-19 and you can read about the human Diabetes trial.

    This company, Adistem, is now filing for patents for TB 4 in Diabetes. This is not RGRX's filing. That is one area RGRX missed.

    I am very curious about this himan trial, TB 4 in Diabetes. The therapy arease seem almpst endlss for TB 4..but will it work well enough in trials. Evidently, an okay trial humans & Diabetes. Unknown to us before.

 
RGRX
0.2362+0.0163(+7.41%)Apr 16 3:54 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Morgan Stanley
NYSEWed, Apr 16, 2014 4:00 PM EDT
Genpact Limited
NYSEWed, Apr 16, 2014 4:02 PM EDT
General Electric Company
NYSEWed, Apr 16, 2014 4:00 PM EDT